Malignant Musculoskeletal Neoplasm — Trials

Malignant Musculoskeletal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

465 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 141
Recruiting: 73
Ph III recruiting: 6
Growth YoY: −28%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (58)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00614835	Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus	completed	N/A	25	Memorial Sloan Kettering Cancer CenterOTHER	1	Dec 22, 2015	clinicaltrials
NCT01674101	Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy	completed	N/A	20	St. Jude Children's Research HospitalOTHER	1	Dec 4, 2015	clinicaltrials